Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)

ClinicalTrials.gov ID: NCT03031418

Public ClinicalTrials.gov record NCT03031418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 11:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study Including Impact on Decision-making and Health Economics.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is investigate a new and validated urine test which predicts the likelihood of high grade prostate cancer on an initial prostate biopsy The current protocol has two objectives; one is to further assess and evaluate the performance of the urine test in men already scheduled for initial prostate needle biopsy (cohort (group) 1) and two, to evaluate how the results of the urine test influences the decision process for determining whether to perform a prostate biopsy (cohort (group) 2).

Study identification

NCT ID
NCT03031418
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Exosome Diagnostics, Inc.
Industry
Enrollment
532 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2016 (Actual)
Primary completion
Sep 1, 2018 (Actual)
Completion
Sep 1, 2018 (Actual)
Last update posted
Dec 29, 2020

2016 – 2018

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
21st Century Oncology Fort Myers Florida 33907 —
Mount Sinai Medical Center of Florida Miami Florida 33140 —
Southeastern Urology Associates Macon Georgia 31217 —
Johns Hopkins University Baltimore Maryland 21287 —
Walter Reed National Military Medical CPDR Bethesda Maryland 20889 —
Comprehensive Urology Royal Oak Michigan 48073 —
Five Valley Urology Missoula Montana 59808 —
Premier Urology Group Edison New Jersey 08837 —
Urologic Research and Consulting LLC Englewood New Jersey 07631 —
Delaware Valley Urology Voorhees Township New Jersey 08043 —
Manhattan Medical Research New York New York 10016 —
NYU Urology Associates New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Columbia University Medical Center New York New York 10032 —
Associated Urologists of North Carolina Raleigh North Carolina 27612 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
UT Health Science Center San Antonio Texas 78229 —
Urology of Virginia Virginia Beach Virginia 23462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03031418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2020 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03031418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →